59 results
Page 2 of 3
POS AM
h53zptjc nd18d
22 Mar 22
Prospectus update (post-effective amendment)
4:07pm
8-K
EX-99.1
ljtwt6pd4rlwf
21 Mar 22
Regulation FD Disclosure
5:12pm
POSASR
oi1dia
21 Mar 22
Automatic shelf registration (post-effective amendment)
4:02pm
8-K
EX-10.1
60b8p3ti7t63g1k
4 Mar 22
Departure of Directors or Certain Officers
4:02pm
8-K
EX-10.1
xdvqy24
16 Aug 21
ORIC Pharmaceuticals Appoints Steven L. Hoerter to its Board of Directors
4:41pm
424B5
lhmj7ad1e6v sou15q
6 May 21
Prospectus supplement for primary offering
5:01pm
S-3ASR
ijmioyd9o6mif8ubx
6 May 21
Automatic shelf registration
4:33pm
S-8
r0nf0skl7yd x2
23 Mar 21
Registration of securities for employees
4:50pm
10-K
5olnt1 xi1y
23 Mar 21
Annual report
4:21pm
8-K
EX-99.2
51e4ubpxkdqv
11 Jan 21
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Milestones
6:36am
424B4
1g5tnrlqdsr6d1ot2o
13 Nov 20
Prospectus supplement with pricing info
5:21pm
DRS
rj6p5v i4rm75snzd
20 Jul 20
Draft registration statement
12:00am